Identification of IFITM3 and MGAT1 as novel interaction partners of BRI3 by yeast two-hybrid screening

BRI3 (brain protein I3) is one of the Wnt/ß-catenin pathway target genes as indicated by the results of serial analysis of gene expression (SAGE) and microarray analyses performed in our laboratory. The Wnt/ß-catenin signaling pathway is an evolutionarily conserved pathway, which has important functions in early vertebrate development, axis formation, cellular proliferation, and morphogenesis. Previous studies showed that BRI3 expression is upregulated at both mRNA and protein levels upon ß-catenin activation by various approaches, such as lithium treatment and overexpression of Wnt ligands in Huh7 (hepatocellular carcinoma) cell lines. Moreover, with regard to the previous literature, BRI3 was found to have a very important role in the TNF?-mediated cell death pathway. In this study, we screened a human liver cDNA library by yeast two-hybrid assay using BRI3 protein as bait, with the aim of finding novel interaction partners of BRI3. Library screening by yeast mating resulted in the identification of three candidate positive clones. Among these, IFITM3 and MGAT1 proteins were confirmed as interaction partners by using cotransformation in yeast cells and coimmunoprecipitation from mammalian cell lines. Considering the poor functional characterization of BRI3 to date, identification of novel BRI3-interacting proteins is an essential first step in determining the action mechanism of BRI3 with respect to the Wnt/ß-catenin pathway.

Keywords:

Wnt/β-catenin signaling, BRI3, SAGE, hepatocellular carcinoma, yeast two-hybrid IFITM3, MGAT1,

PDF

___

Akiva I, Birgül Iyison N (2018). MGAT1 is a novel transcriptional target of Wnt/β-catenin signaling pathway. BMC Cancer 18: 82-88.
Andreu P, Colnot S, Godard C, Laurent-Puig P, Lamarque D, Kahn A, Perret C, Romagnolo B (2006). Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res 66: 1949-1956.
Behrens J, Von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W (1996). Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382: 638-642.
Cadigan KM, Nusse R (1997). Wnt signaling: a common theme in animal development. Gene Dev 11: 24-32.
Fan J, Peng Z, Zhou C, Qiu G, Tang H, Sun Y, Wang X, Li Q, Le X, Xie K (2008). Gene-expression profiling in Chinese patients with colon cancer by coupling experimental and bioinformatic genomewide gene-expression analyses: identification and validation of IFITM3 as a biomarker of early colon carcinogenesis. Cancer 113: 266-275.
Kavak E, Najafov A, Ozturk N, Seker T, Cavusoglu K, Aslan T, Duru AD, Saygili T, Hoxhaj G, Hiz MC et al. (2010). Analysis of the Wnt/B-catenin/TCF4 pathway using SAGE, genome-wide microarray and promoter analysis: identification of BRI3 and HSF2 as novel targets. Cell Signal 22: 1523-1535.
Rubinfeld B, Souza B, Albert I, Müller O, Chamberlain SH, Masiarz FR, Munemitsu S, Polakis P (1993). Association of the APC gene product with beta-catenin. Science 262: 1731-1734.
Wodarz A, Nusse R (1998). Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Bi 14: 59-88.
Wu H, Liu G, Li C, Zhao S (2003). Bri3, a novel gene, participates in tumor necrosis factor-alpha-induced cell death. Biochem Bioph Res Co 14: 518-524.
Yamazaki T, Sasaki N, Nishi M, Yamazaki D, Ikeda A, Okuno Y, Komazaki S, Takeshima H (2007). Augmentation of drug- induced cell death by ER protein BRI3BP. Biochem Bioph Res Co 362: 971-975.
Ye Q, Singh K, Blonde JD, Jia Z (2004). Crystallization and preliminary X-ray analysis of the GST-fused human Bri3 N-terminal domain. Struct Biol Cryst Commun 61: 62-64.
Zhou W, Wang GQ, Xiao J, Yu H, Lin LZ, Zhao Q, Zhao SY, Li CB (2000). Isolation of TNF-α related genes expressing in the endothelial cells by suppression subtractive hybridization. High Tech Lett 10: 9-11.